Showing 1351-1360 of 2155 results for "".
- BTL Launches EMSCULPT NEO Edge Applicator for the Lateral Abdomenhttps://modernaesthetics.com/news/btl-launches-emsculpt-neo-edge-applicator-for-the-lateral-abdomen/2473265/BTL is launching the new Edge™ Applicators to treat the entire lateral abdomen. Shipping will begin in
- FDA Nod for Sientra’s Low Plus Profile Projection Breast Implanthttps://modernaesthetics.com/news/fda-nod-for-sientras-low-plus-profile-projection-breast-implant-1/2473263/The U.S. Food and Drug Administration (FDA) approved Sientra’s Low Plus Profile Projection Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for board-certi
- Bryant Wong Named Sciton’s first CFOhttps://modernaesthetics.com/news/bryant-wong-named-scitons-first-cfo/2473259/Bryant Wong is Sciton’s first Chief Financial Officer, effective immediately. The announcement was made at Sciton's 25th Anniversary celebration. The year 2022 exemplifies Sciton's ongoing commitment to quality and improvement, with recognition such as 2022 Company of the
- Bausch Health Suspends Plans for Solta IPOhttps://modernaesthetics.com/news/bausch-health-suspends-plans-for-solta-ipo-1/2473255/Bausch Health Companies Inc. is suspending its plans for the Solta IPO due to challenging market conditions and other factors. Bausch Health stated that the interests of the Company's stakeholders are best served in the near-term by focusing on driving Solta's revenue, profits a
- BeautyHealth Appoints Bluemercury Founder Marla Beck to Board of Directorshttps://modernaesthetics.com/news/beautyhealth-appoints-bluemercury-founder-marla-beck-to-board-of-directors/2473249/Bluemercury founder Marla Beck is now a member ofThe Beauty Health Company’s Board of Directors. As founder and former CEO of Bluemercury, the disruptive omnichannel beauty retailer founded in 1999 and acquired by Macy’s in 2015, Ms. Beck has a track record of building
- Plastic Surgery Residents Report Barriers to Affordable Childcarehttps://modernaesthetics.com/news/plastic-surgery-residents-report-barriers-to-affordable-childcare/2473246/Plastic surgery residents face persistent barriers accessing affordable childcare, with high costs and a major impact on surgical training—with most of the burden falling on women residents, finds a study in the June issue of Plastic and Reconstructive Surgery. The researchers sen
- CoolSculpting's New DTC Campaign is Brand's First to Feature Real Experiences with Treatmenthttps://modernaesthetics.com/news/coolsculptings-new-dtc-campaign-is-brands-first-to-feature-real-experiences-with-treatment/2473238/The newest direct-to-consumer campaign from CoolSculpting® launches this month and marks the first time the brand is featuring the real experiences of real people who have been treated with CoolSculpting® and CoolTone®. “CoolSculpting® Takes You Further&rdquo
- CellFX from Pulse Biosciences Shows Durable Effects for Sebaceous Hyperplasia: ASLMS Presentationhttps://modernaesthetics.com/news/cellfx-from-pulse-biosciences-shows-durable-effects-for-sebaceous-hyperplasia-aslms-presentation/2473233/The CellFX® system from Pulse Biosciences, Inc. demonstrates durable efficacy for the clearance of Sebaceous Hyperplasia lesions, according to data presented at the 2022
- Colorescience, Aesthetics Biomedical Join Forces for New Collabhttps://modernaesthetics.com/news/colorescience-aesthetics-biomedical-join-forces-for-new-collab/2473229/Colorescience and Aesthetics Biomedical are launching a collaboration that combines Vivace Microneedle RF with a post-treatment protocol featuring Colorescience’s Sunforgettable Total Protection Brush-On Shield SPF 50. Patients opting for the radiofrequency microneedlin
- Elevai Labs Names Chief Marketing and Brand Advisorhttps://modernaesthetics.com/news/elevai-labs-names-chief-marketing-and-brand-advisor/2473228/Brenda Buechler is now Chief Marketing and Brand Advisor for Elevai Labs, Inc. Elevai is a science-based aesthetic skincare company providing topical formulations featuring by ethically sourced, human umbilical mesenchymal stem cells (hUMSC)-derived e